Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients

Nephrology Dialysis Transplantation

Volumn 23, Issue 7, 2008, Pages 2393-2398

  Aguilera, Isabel ^a   Alvarez Marquez, Antonia ^a   Gentil, Miguel Angel ^a   Fernandez Alonso, Jorge ^a   Fijo, Julia ^a   Saez, Carmen ^a   Wichmann, Ingeborg ^a   Nuñez Roldan, Antonio ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Antibody mediated rejection; C4d; Genetic mismatch; GSTT1

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C4D; GLUTATHIONE TRANSFERASE T1; GLUTATHIONE TRANSFERASE T1 ANTIBODY; HLA ANTIBODY; HLA ANTIGEN;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CASE REPORT; CHRONIC GRAFT REJECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LOCALIZATION; GENE; GRAFT RECIPIENT; GSTT1 GENE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALLELES; ANTIBODIES, ANTI-IDIOTYPIC; BIOPSY; COMPLEMENT C4B; FOLLOW-UP STUDIES; GLUTATHIONE TRANSFERASE; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MIDDLE AGED; PEPTIDE FRAGMENTS; TRANSPLANTATION, HOMOLOGOUS;

EID: 46849106934     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm955     Document Type: Article

References (16)

1. Halloran PF, Wadgymar A, Ritchie S et al. The significance of the anti-class I response: I. Clinical and pathologic features of anti-class I-mediated rejection. Transplantation 1990; 49: 85-91
2. Sumitran-Holgersson S, Holgersson J. Clinical importance of non-HLA antibodies in solid organ transplantation. Curr Opin Organ Transplant 2006; 11: 425-432
3. Feucht HE, Schneeberger H, Hillebrand G et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333-1338
4. Böhmig G, Regele H. Diagnosis and treatment of antibody-mediated kidney allograft rejection. Transpl Int 2003; 16: 773-787
5. Solez K, Colvin RB, Racusen LC et al. Banff 05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ("CAN"). Am J Transpl 2007; 7: 518-526
6. Aguilera I, Wichmann I, Gentil MA et al. Alloimmune response against donor glutathione S-transferase T1 antigen in renal transplant recipients. Am J Kid Dis 2005; 46: 345-350
7. Aguilera I, Sousa JM, Gavilán F et al. Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation. Liver Transpl 2004; 10: 1166-1172
8. Pemble S, Schroeder KR, Spencer SR et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300: 271-276
9. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000; 463: 247-283
10. Halloran PH, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999; 10: 167-181
11. Harrison DJ, Kharbanda R, Bishop D et al. Glutathione S-transferase isoenzymes in human renal carcinoma demonstrated by immunohistochemistry. Carcinogenesis 1989; 10: 1257-1260
12. Kharbanda R, Lauder J, Thomson D et al. Heterogeneity of glutathione S-transferase isoenzyme expression in renal tissue. Nephrol Dial Transplant 1991; 6: 695-700
13. Murray GI, Paterson PJ, Weaver RJ et al. The expression of cytochrome P-450, epoxide hydrolase and glutathione S-transferase in hepatocellular carcinoma. Cancer 1993; 71: 36-43
14. Harrison DJ, Kharbanda R, Cunningham DS et al. Distribution of glutathione S-transferase isoenzymes in human kidney: basis for possible markers of renal injury. J Clin Pathol 1989; 42: 624-628
15. Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005; 5: 807-817
16. Smith RN, Kawai T, Boskovic S et al. Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates. Am J Transpl 2006; 6: 1790-1798